Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Mesothelioma × Ramucirumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Stomach Neoplasms 16 Carcinoma, Non-Small-Cell Lung 8 Neoplasm Metastasis 3 Adenocarcinoma 3 Squamous Cell Carcinoma of Head and Neck 2 Lung Neoplasms 2 Adenocarcinoma Of Esophagus 2 Thymoma 1 Recurrence 1 Pancreatic Neoplasms 1 Neoplasms 1 Mesothelioma, Malignant 1 Mesothelioma 1 Locally Advanced Unresectable Gastric Adenocarcinoma 1 Head and Neck Neoplasms 1 Gliosarcoma 1 Glioblastoma 1 Gastroesophageal Cancer 1 Gallbladder Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Clinical Stage III Gastric Cancer AJCC v8 1 Cholangiocarcinoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Hepatocellular 1 Carcinoid Tumor 1 Brain Neoplasms 1 Advanced Gastric or EGJ Cancer 1 Advanced Gastric Cancer 1 Adenocarcinoma of the Oesophagus 1

Interventions

Pemetrexed 20 Cisplatin 17 Nivolumab 7 Gemcitabine 7 Carboplatin 7 durvalumab 5 Radiotherapy, Intensity-Modulated 4 Ipilimumab 4 Bevacizumab 4 tremelimumab 3 pembrolizumab 3 niraparib 3 Cerebral Decortication 3 Blood Specimen Collection 3 sargramostim 2 Thoracoscopy 2 Surveys and Questionnaires 2 Sorafenib 2 Radiosurgery 2 Oxaliplatin 2 Magnesium Sulfate 2 Leucovorin 2 Imatinib Mesylate 2 Drug Therapy 2 Doxorubicin 2 Dexamethasone 2 Cyclophosphamide 2 sodium thiosulfate 1 pevonedistat 1 perflutren 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03560973 2025-03-13

RAMES

Gruppo Oncologico Italiano di Ricerca Clinica

Phase 2 Completed

Other solid neoplasmThoracic

Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡